Use of tissue plasminogen activator in the treatment of shunt blockage secondary to intraventricular haemorrhage

J Clin Neurosci. 2016 Dec:34:281-282. doi: 10.1016/j.jocn.2016.05.011. Epub 2016 Aug 10.

Abstract

A 51-year-old woman with a history of idiopathic aqueduct stenosis, treated initially with insertion of a ventriculo peritoneal shunt, presented to our institution with shunt dysfunction. She had previously undergone multiple shunt revisions for shunt infection, shunt blockage and low-pressure symptoms, most recently with conversion to a ventriculo atrial (VA) shunt. Her VA shunt was again revised, with replacement of the ventricular catheter, however surgery was complicated by a large intraventricular haemorrhage (IVH) requiring placement of an external ventricular drain (EVD). Prior to eventual removal of her EVD it was determined that the VA shunt had blocked as a result of the IVH. Subsequently alteplase, a recombinant tissue plasminogen activator (tPA), was administered into the shunt reservoir, resulting in successful return of shunt function, therefore avoiding the need for further shunt revision. This is the first description of the use of tPA to unblock a shunt obstructed by blood.

Keywords: Hydrocephalus; Intraventricular haemorrhage; Shunt obstruction; Tissue plasminogen activator; Ventriculo atrial shunt; Ventriculo peritoneal shunt blockage.

Publication types

  • Case Reports

MeSH terms

  • Cerebral Hemorrhage* / complications
  • Cerebral Hemorrhage* / drug therapy
  • Cerebral Hemorrhage* / surgery
  • Cerebral Ventricles / pathology
  • Cerebral Ventricles / surgery*
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / pharmacology*
  • Humans
  • Middle Aged
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / pharmacology*
  • Ventriculoperitoneal Shunt / adverse effects*

Substances

  • Fibrinolytic Agents
  • PLAT protein, human
  • Tissue Plasminogen Activator